DHA and Dementia: Preserving Cognition in the Aging Patient CME/CE

Author Information and Disclosures

Release Date: May 14, 2008; Valid for credit through May 16, 2008

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

This live event has already occurred. For the archived version of this event and to participate in the CME activity, please click on the link below.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Martek
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME/CE Information
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe the neurologic, cellular, and metabolic etiologies of dementia
  2. Detail the utility of omega-3 fatty acids and DHA in minimizing age-related neurodegenerative disorders and Alzheimer's disease
  3. Discuss recent studies that suggest a neuroprotective effect associated with the use of DHA
Authors and Disclosures

Greg M. Cole, PhD
Disclosure: Greg M. Cole, PhD, has disclosed no relevant financial relationships.


Sally A. Frautschy, MS, PhD
Disclosure: Sally A. Frautschy, MS, PhD, has disclosed that she has received National Institutes of Health grants for biomedical research on Alzheimer's disease.


Robert Chevrier
Disclosure: Robert Chevrier has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.